Latest Regulatory News

HiTech Group Australia has tabled a conditional $15 million offer to acquire selected assets and employees from Hudson Global Resources, targeting the UpperGround business. The deal hinges on creditor approval, regulatory clearance, and financing, with payments structured across upfront, conditional, and deferred components.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

PointsBet’s FY26 nine-month report reflects a transitional period marked by MIXI’s 66.4% takeover, a slight revenue dip to AUD 186.6 million, and a near breakeven normalised EBITDA. Australian revenue softened by 4%, while Canada grew 13% driven by iGaming momentum.

ClearView Wealth has lodged its Scheme Booklet with ASIC, outlining Zurich's $0.65-per-share takeover offer and setting the stage for a pivotal shareholder vote on 27 July 2026.

Altair Minerals has completed the second tranche of a premium priced placement, raising a total of A$28.2 million from Endeavour Mining, which now holds a 9.9% stake. The funds boost Altair’s treasury to about A$38 million, underpinning an expansive multi-year exploration push in Guyana.

Western Australia's State Government has backed VRX Silica's land swap proposal at Muchea, unlocking access to a significantly larger high-grade silica sand resource with lower environmental impact and paving the way for downstream glass manufacturing.

CONNEQT Health has lodged an FDA Pre-Submission for SphygmoCor Cloud, aiming to shift its arterial health analytics from hardware to a scalable software platform with broad commercial potential.

Quinbrook Asset Management has lodged a review application challenging a recent Takeovers Panel decision involving Kingsland Minerals. The Panel President has approved the application, but no review Panel has been formed yet.

Elementos Limited has secured a key regulatory milestone as the Regional Government of Andalucía grants its Oropesa Tin Project Overriding Public Interest status, easing the path for critical water licensing and advancing permitting certainty.

Orpheus Uranium (ASX: ORP) is set to kick off its inaugural drilling program at the Erudina Uranium Prospect within the Frome Project, targeting a 10 km-long palaeochannel system with the aim of refining geological models and advancing towards a potential mineral resource.